NEXT&BIO expands Singapore R&D operations to advance translational cancer research in Asia

Singapore, Oct. 9 -- NEXT&BIO, an affiliate of Kolmar Holdings, has announced the expansion of its research and development (R&D) operations in Singapore. Supported by the Singapore Economic Developme... Read More

Korea's LOTTE Biologics inks US-based manufacturing agreement with Alvotech to increase global supply

Singapore, Oct. 9 -- South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global biotechnology company specialising in the development and m... Read More

Japan's Third Way: BioJapan Day 2 Maps the Routes Out and the Reasons to Come In

Singapore, Oct. 8 -- If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIFICO Yokohama got down to the practical business of closing ... Read More

Andelyn Biosciences and PQP Group partner to streamline EU and UK supply pathways for cell and gene therapies

Singapore, Oct. 8 -- Andelyn Biosciences ("Andelyn"), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization ("CDMO"), and PQP Group announced a s... Read More

S$25 M Healthy Longevity Institute and global brain health collaboration to advance healthy ageing in Singapore

Singapore, Oct. 8 -- Nanyang Technological University, Singapore (NTU Singapore), NHG Health and the Geriatric Education and Research Institute (GERI) have launched the Healthy Longevity Institute (HE... Read More

Korea's GC Cell and Israel-based QuantHealth collaborate to optimise clinical cevelopment of cell therapy product

Singapore, Oct. 8 -- South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and Israel-based QuantHealth, the global leader in AI-powered ... Read More

Japan's Shionogi continues rare disease expansion with acquisition of IntraBio for $2 B

Singapore, Oct. 8 -- Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company developing and commercialising therapies for neurodegenerative diseas... Read More

GE HealthCare buys SOFIE Biosciences for $945 M to establish 'Final Mile' footprint for PET Radiopharmaceutical Supply in US

Singapore, Oct. 8 -- GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase ... Read More

Charles River and Autolomous launch Apollo Orchestrate for digital laboratory execution

Singapore, Oct. 8 -- Charles River Laboratories International, Inc. and Autolomous announced the launch of Apollo Orchestrate on October 6, 2026, a new capability within Charles River's Apollo platfor... Read More

Novartis signs licensing deal worth $7.2 B with China's Abogen for mRNA therapies

Singapore, Oct. 7 -- China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered into a licensing and option agreement with Novartis to advance ... Read More

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»